Abstract
Background:
The modified Blalock-Taussig-Thomas shunt (mBTTS) is a critical palliative procedure for infants with single-ventricle physiology, but thrombosis-related occlusion affects 8% to 12% of infants and carries nearly 50% mortality. Meanwhile, existing antithrombotic strategies fail to address the hemodynamic factors driving thrombosis, highlighting the need for a deeper understanding of flow dynamics in shunt failure.
Objectives:
This study aims to identify how mBTTS geometry influences hemodynamics and thrombosis risk, providing quantitative guidance for surgical planning and shunt design optimization.
Methods:
We used patient-specific imaging data to test 54 idealized mBTTS configurations, systematically varying key geometric factors: pulmonary artery diameter, shunt diameter, and insertion angle. Using computational fluid dynamics, we analyzed how these variables influence wall shear rate, elongation strain rate, and turbulence intensity, as well as hemodynamic parameters known to influence thrombosis risk, to identify patterns linked to thrombosis.
Results:
We computationally identified optimal geometric configurations. Peak wall shear rate and elongation strain rate were primarily located at bifurcation points, whereas peak turbulence intensity was concentrated within the shunt channel. Shunt insertion distal to the right carotid artery with a 60° insertion angle and with a 4.0-mm shunt graft demonstrated the most favorable hemodynamic profiles for clot prevention in infants. Statistical analysis confirmed strong correlations between geometric parameters and flow characteristics.
Conclusions:
Results provide a framework for optimizing mBTTS design to reduce thrombosis risk based on hemodynamic risk factors, including actionable recommendations for shunt placement and design. These insights provide a foundation for hemodynamically guided surgical interventions with the potential to improve survival rates in this high-risk patient population and for broader applications in cardiovascular surgery.
Keywords: hemodynamics, thrombosis, pediatric heart disease, shear, turbulence, elongational flow, engineering
Graphical Abstract

CFD enables thrombosis risk stratification based on shunt geometry and flow dynamics.
The modified Blalock-Taussig-Thomas shunt (mBTTS) (Figure 1, A) is a life-saving palliative procedure for infants with cyanotic or single-ventricle heart disease. Yet, thrombosis occurs in 8% to 12% of patients, carrying up to 50% mortality despite therapy with antithrombosis agents.1–7 mBTTS failure from partial or complete occlusion remains life-threatening, requiring emergency intervention to restore patency.8–13 High vigilance is essential and the financial burden is considerable, estimated at $1.3 to $2.9 million per patient or $74 billion across all complex congenital heart disease cases.14 Those who survive early complications face significantly lower 5-year survival (33%−40% vs 77%).4,8,15 Current antithrombosis guidelines, largely unchanged since 2013,1 rely on acute therapies (high-dose heparin; vasopressors; ventilatory support; or catheter-based or surgical thrombectomy, sometimes with extracorporeal membrane oxygenation). Preventive strategies depend on antiplatelet and anticoagulant agents but have weak evidence, limited monitoring, and risks such as bleeding and heparin-induced thrombocytopenia.1,8,13,E1 There remains a need to reconsider strategies for improving outcomes.
FIGURE 1.

Development and characterization of the idealized modified Blalock-Taussig shunt (mBTTS) computational model. A, Patient-derived mBTTS geometry showing key parameters: distance to right carotid artery , shunt diameter , pulmonary artery diameter , and shunt-pulmonary artery insertion angle . B, Simplified H-model preserving critical anatomy while standardizing vessel paths and bifurcation for controlled geometric analysis. Boundary conditions include a constant inlet velocity (Q); outlet flows (Q1-Q4) follow Murray’s Law. C, Cross-sectional mesh with 10 inflation layers (first layer: 1 × 10−5 m) for boundary layer resolution. D, Full domain with inlet/outlet extensions (10 × subclavian diameter) to ensure developed flow; extensions shown in darker shade (green).
Retrospective review of mBTTS placement implicates geometric differences between patent and occluded shunts as a potential contributing factor.16 It is assumed that geometry influences local prothrombotic hemodynamics, which are neglected by current therapies.17–20 Specific hemodynamic factors in a precision health approach linked to thrombosis include wall shear rate (WSR), elongation strain rate (ESR), and turbulence. WSR quantifies velocity gradients at vessel walls, where adjacent layers of blood slide past each another, reflecting shear stresses exerted by the fluid. In contrast to WSR, ESR involves blood elements being stretched or elongated along the direction of flow, a process known to extend long chains.21 High WSR/ESR can promote thrombosis by activating platelets through a von Willebrand factor (VWF)-dependent mechanism where fluid stress extends VWF, exposing key sites (Figure 2).18,22–29 Turbulence involves velocity fluctuations, which could amplify platelet-platelet and platelet-protein interactions and mechanical stress, contributing to thrombosis risk.30,31 By controlling the orientation of the inserted shunt for mBTTS, it may be possible to reduce these prothrombotic hemodynamics.
FIGURE 2.

Effects of wall shear rate (WSR) and elongational strain rate (ESR) on platelet activation. Top, High WSR elongates von Willebrand factor (VWF), promoting platelet adhesion and aggregation via glycoprotein Ib-IX-V binding. Bottom, ESR stretches VWF along flow lines, exposing platelet binding sites and enhancing VWF self-association. Both high WSR and ESR drive VWF-mediated thrombosis, whereas low shear may promote clotting via prolonged cell residence and coagulation activation.
We propose to use computational fluid dynamics (CFD) in a precision health approach to identify shunt configurations that minimize thrombogenic flow. Our simulations enable systematic exploration of geometric configurations difficult to study surgically, providing precise control of key variables. By analyzing how geometry influences WSR, ESR, and turbulence intensity (TI), we aim to identify design principles that reduce thrombosis risk and guide surgical planning.
METHODS
Study Overview and Model Development
Building on prior identified geometric risk factors for mBTTS thrombosis16 in a local cohort (weight, 2.8–4.1 kg), we developed idealized computational models to systematically assess how specific geometric features influence thrombogenic flow. This study was approved by Washington University’s institutional review board (ID# 202303162; March 29, 2023).
Using SimVascular (SimVascular), we first generated 3-dimensional mBTTS anatomies from patient computed tomography/magnetic resonance imaging. Insights from these models guided creation of a simplified H model (Figure 1, B) that enabled precise control of key geometric parameters while excluding confounding factors. This approach aligns with established computational hemodynamics methods, where idealized models are used to isolate relationships between flow and geometry before reintroducing complexity.32–37 Inlet and outlet extensions (10 × subclavian vessel diameter) ensured fully developed flow at the mBTTS region (Figure 1, D). Future validation studies will reintroduce patient-specific anatomy to confirm clinical relevance in more complex geometries.
Geometric Parameter Selection and Model Generation
Four key geometric parameters were identified from our previous clinical study.16 Three parameters were evaluated across the minimum, median, and maximum values observed in our clinical cohort (Table 1) that can be studied in the idealized H model: the distance between shunt insertion and right carotid artery (RCA) insertion (−7 to +7 mm, with negative values indicating insertion distal to the RCA), the insertion angle between the shunt and the pulmonary artery (PA) (60°−120°), and the PA diameter (2.5–5.0 mm). The fourth parameter, shunt diameter , was evaluated at 2 clinically standard sizes: 3.5 mm and 4.0 mm. This resulted in 54 unique geometric configurations, each maintaining consistent vessel paths while varying only the specified parameters. In addition, shunt length (10.9–20.4 mm) and shunt tortuosity (1.0–1.12 mm) were evaluated specifically in the safest and most thrombogenic configurations because they are controllable by the surgeon. Tortuous grafts curved 1 mm from the proximal anastomosis and 2 mm from the distal anastomosis to a controlled arc length (Figure E1, A). Tortuosity was calculated as the ratio of the trimmed centerline length (arc length) to the straight-line (Euclidean) distance between its start and end points. Different curvature directions (convex vs concave) were analyzed as well (Figure E1).
TABLE 1.
Geometric parameter ranges used in computational analysis of modified Blalock-Taussig shunt (mBTTS) configurations. Summary of parameters across 54 modeled configurations*
| Variable | (mm) | (°) | (mm) | (mm) |
|---|---|---|---|---|
| Minimum | −7 | 60 | 2.5 | 3.5 |
| Median | 0 | 90 | 3.75 | |
| Maximum | 7 | 120 | 5.0 | 4.0 |
, Distance from shunt to right carotid artery (negative = proximal, positive = distal); , shunt-pulmonary artery insertion angle; , pulmonary artery diameter; , shunt diameter.
Values were derived from patient-specific imaging data.22
Inlet flow was constant (1 L/min), and outflow ratios were calculated using Murray’s Law38 based on derived median vessel radii (Table E1), distributing flow amongst the RCA, right subclavian artery, and PAs. This approach simplifies physiology, neglecting the ratio between pulmonary vascular resistance and systemic vascular resistance that would alter flow distributions in vivo. Future models incorporating patient-specific resistances could improve presurgical planning in patients with pulmonary hypertension or altered vascular resistance.
Mesh Generation and Validation
A mesh was generated in geometry using Ansys Fluent (Ansys). To capture boundary layer effects, 10 prismatic inflation layers were added near the vessel walls, with tetrahedral elements throughout the remaining volume (Figure 1, C). Mesh convergence was reached with ~800,000 cells, and mesh quality was evaluated using standard quality metrics with all values within acceptable thresholds (maximum skewness <0.82, minimum orthogonal quality >0.20, and maximum aspect ratio <40).
Computational Flow Analysis
Blood flow simulations were performed using Ansys Fluent with the steady-state, k- shear stress transport turbulence model, with a low Reynolds number correction. Blood was treated as a Newtonian fluid with constant density and viscosity (0.004 kg/m/sec). We applied no-slip boundary conditions at rigid walls and specified constant velocity inlet profiles based on median flow velocities measured by Doppler echocardiography in our patient cohort.16 Steady-state flow was used to minimize confounding variables and isolate geometric effects. The inlet Reynolds number (1830), although indicated laminar flow for a straight vessel, could lead to flow instability in bifurcations. For each configuration, we calculated 4 hemodynamic parameters associated with thrombosis risk. WSR was calculated as:
| (1) |
where is blood velocity parallel to the wall and is the distance perpendicular to the wall. ESR was quantified as the rate of stretching along the flow streamlines:
| (2) |
where is the strain rate tensor and is the blood velocity at a point. TI was quantified as:
| (3) |
where is the time average of and is the turbulent kinetic energy representing the mean kinetic energy per unit mass associated with turbulent velocity fluctuations.
Power loss was quantified dissipation across the model39:
| (4) |
where is the static pressure, is the velocity component normal to the inlet/outlet surface (positive outward), and is cross-sectional area.
A parameter classified extensional versus rotational flow40:
| (5) |
where is the vorticity tensor and and are Frobenius norms, in which represents the trace of a tensor. corresponds to pure extensional flow, represents pure rotational flow, and indicates simple shear.
Optimization
To objectively identify optimal geometric configurations, we applied a composite score balancing ESR, WSR, and TI:
| (6) |
where subscript max and min represent extrema over all geometric parameters, and indicates a specific parameter combination. Weighting factors , and were determined using principal component analysis. Lower represents more optimal configurations.
Statistics
Data were summarized using frequencies with percentages, means ± SD, or medians with interquartile range, as appropriate. Spearman’s correlation coefficient was used to assess associations between parameters and shunt insertion outcomes. Differences among parameters with 3 levels were compared using analysis of variance, followed by Tukey-adjusted pairwise comparisons when the overall model was significant. If normality was violated, rank-transformed data were analyzed. For 2-level parameters, either a 2-sample test or Wilcoxon rank-sum test was applied based on data distribution. Analyses were conducted in SAS version 9.4 (SAS Institute Inc).
RESULTS
Spatial Distribution of Peak Flow Characteristics
Analysis of the 54 mBTTS configurations revealed distinct peak locations for each flow metric (Figure 3, C, F, and I, and Table E2). WSR peaks occurred primarily at bifurcation points, with 46.3% at the distal attachment corner of the shunt-subclavian artery junction, 29.6% at the proximal attachment corner, 20.4% (11 models) at the RCA insertion, and 3.7% (2 models) along the shunt wall. ESR peaks were similarly concentrated at junctions, with 66.7% occurring at the distal corner of the shunt-subclavian artery junction, 27.8% at the RCA bifurcation, and 1.8% at the shunt-PA junction. TI peaks differed, with 70.4% occurring within the shunt conduit, 11.1% at the inlet, 7.4% distal to the shunt insertion, and 5.6% split equally between the carotid and shunt-PA junctions. Representative contour plots show the distribution of WSR, ESR, and TI across the model (Figure 3, A, B, D, E, G, and H).
FIGURE 3.

Spatial distribution and comparison of extreme flow parameters across modified Blalock-Taussig shunt (mBTTS) geometries. Contour plots show models with maximum and optimized values for each hemodynamic parameter over a cardiac cycle. Schematics summarize peak locations across 54 configurations; circle size reflects frequency of peak occurrence. A, Maximum wall shear rate (WSR): 61,404 s−1, (pulmonary artery diameter , shunt diameter ). B, Optimized WSR: 24,216 s−1 . C, WSR peaks (blue): mostly at shunt-subclavian anastomosis. D, Maximum elongational strain rate (ESR): 7911 s−1 (distance to right carotid artery [RCA] , shunt-PA insertion angle ). E, Optimized ESR: 2741 s−1 . F, ESR peaks (orange): at distal shunt-subclavian junction (66.7%) and carotid bifurcation (27.8%). G, Maximum turbulence intensity (TI): 33.9%, . H, Optimized TI: 6.8% . I, TI peaks (purple): primarily within the shunt (70.4%). Arrows indicate flow direction. Percentages based on all simulated configurations. RSCA, Right subclavian artery.
Influence of Geometric Parameters on Flow Characteristics
Statistical analysis revealed correlations between geometric parameters and flow characteristics (Figure E2 and Table E3). Moving the shunt insertion from proximal to distal moderately decreased ESR and TI, with WSR showing a similar but nonsignificant trend . A larger reduced ESR but increased TI . strongly correlated with all flow metrics , whereas was inversely associated with WSR and showed weak, nonsignificant effects on ESR and TI.
Overall and pairwise comparisons confirmed these trends (Figure 4). Significant effects were observed for and , with increasing all flow metrics, especially TI . significantly influenced ESR and TI , whereas selectively influenced WSR . These findings identify and as key determinants of all flow metrics, with and exerting more targeted effects.
FIGURE 4.

Influence of geometric parameters on hemodynamic metrics. Analysis of the relationships between geometric parameters and flow metrics (wall shear rate [WSR], elongational strain rate [ESR], and turbulence intensity [TI]). Box plots display median, quartiles, and range for each parameter level. Overall and pairwise values highlight significance across all geometric variations. A, Distance from shunt to right carotid artery . B, Shunt-pulmonary artery insertion angle . C, Pulmnary artery diameter . D, Shunt diameter . Changes in any parameter produced significant shifts in at least 1 flow metric, emphasizing the sensitivity of modified Blalock-Taussig shunt (mBTTS) geometry to thrombosis-related flow alterations. (25th-75th quartiles: A, 31,500–42300, 27,900–41200, 31,300–37800; 4490–5920, 3860–6460, 3700–5050; 23%−28%, 24%−28%, 15%−27%. B, 37,300–41200, 27,600–37400, 31,500–41800; 4100–6030, 4590–5740, 3690–4490; 20%−26%, 22%−28%, 23%−31%. C, 27,900–37300, 27,900–39200, 37,400–42300; 3700–4800, 3740–5570, 4620–5920; 7%−24%, 23%−27%, 26%−30%. D, 32,600–44300, 28,100–38600; 3850–5870, 3820–5740; 21%−29%, 22%−27%).
Models exhibiting extreme values for each flow metric demonstrated distinct geometric configurations (Table 2). Maximum WSR (61,400 s−1) occurred in a model with and , whereas minimum WSR (24,200 s−1) was observed with and . Peak ESR (7910 s−1) was found in a configuration with and , whereas minimum ESR (2740 s−1) occurred with and . Maximum TI (33.9%) was observed in the same configuration as peak WSR, whereas minimum TI (6.8%) occurred in a model with , and .
TABLE 2.
Geometric parameters of models exhibiting extreme flow characteristic*
| Variable | Model | (mm) | (°) | (mm) | (mm) | Peak value |
|---|---|---|---|---|---|---|
| Max peak WSR | DP 44 | 0 | 120 | 5.0 | 3.5 | 61,400 |
| Min peak WSR | DP 11 | 0 | 120 | 2.5 | 4.0 | 24,200 |
| Max peak ESR | DP 36 | −7 | 60 | 5.0 | 3.5 | 7910 |
| Min peak ESR | DP 32 | 7 | 120 | 3.75 | 3.5 | 2740 |
| Max peak TI | DP 44 | 0 | 120 | 5.0 | 3.5 | 33.9% |
| Min peak TI | DP 15 | 7 | 60 | 2.5 | 4.0 | 6.8% |
, Distance from shunt to right carotid artery (negative = proximal, positive = distal); , shunt-pulmonary artery insertion angle. , pulmonary artery diameter; , shunt diameter; WSR, wall shear rate; DP, design point; ESR, elongational shear rate; TI, turbulence intensity.
Configuration details and peak values for models demonstrating maximum and optimized values of each flow characteristic. Each row represents a specific model configuration identified during systematic analysis of 54 geometric variants.
Geometric Configurations Associated With Flow Optimization
Analysis of all configurations that consistently minimized or maximized potentially adverse flow characteristics was identified through the optimization method defined by equation 6 (Figure 5). By applying the optimization approach, the weighting factors for WSR, ESR, and TI were determined as 0.38, 0.25, and 0.37, respectively, when calculating the optimization factor, (Table E2). We ranked all 54 models by value and identified clear trends. The 6 models with the lowest values shared and , whereas the 5 highest value models had and . These patterns suggest is particularly sensitive to 1 or more of these parameters. Surface plots of against geometric parameter pairs (Figure E3) further supports this. Lower values are observed in models with either and the smallest , or and the smallest . Together, these findings indicate that a distal shunt insertion , a 4-mm , and a smaller are associated with more favorable hemodynamic characteristics. This choice additionally depends on flow resistance, a surrogate for systemic steal (Table E2), which is largest for small shunt diameters. Increasing shunt angle generally increases resistance. Power loss was highest for smaller and shunt insertion proximal to the carotid bifurcation. Shunt placement influences both in-graft hemodynamics and the amount of flow expected to pass through the shunt.
FIGURE 5.

Comparative analysis of safest and most thrombogenic modified Blalock-Taussig shunt (mBTTS) configurations. Models selected based on composite optimization factor , reflecting balance of wall shear rate (WSR), elongational strain rate (ESR), and turbulence intensity (TI). The safest model minimizes all 3 metrics; the most dangerous model maximizes them. A and B, Contour plots of factor on the symmetry plane and vessel wall for both models. C, Flowtype parameter on the symmetry plane, comparing dominant flow regimens.
The configuration demonstrating most favorable flow ( WSR = 32,300 s−1, ESR = 3080 s−1, and TI = 6.8%) combines a distal shunt insertion , acute PA angle , minimal , and larger . remained uniformly low across the domain (Figure 5, A and B). The configuration associated with the highest-risk flow characteristics ( WSR = 60,500 s−1, ESR = 5920 s−1, and TI = 33.3%) combined proximal shunt insertion , obtuse PA angle , maximal , and smaller . High values were concentrated at the shunt-subclavian junction and shunt-PA connection, especially along the shunt and near bifurcating zones, primarily driven by TI. Intermediate configurations showed consistent trends where distal shunt insertions combined with acute angles reduced independent of vessel diameters. Models with demonstrated more moderate flow characteristics across all measured parameters compared with those with larger PA diameters.
To further evaluate thrombogenicity, , representing elongational flow and linked to VWF extension, was mapped across the symmetry plane. For the lowest configuration, was centered around 0, corresponding to simple shear, with small positive values (extensional flow) near bifurcations and stagnation points (Figure 5, C). Negative was minimal at the shunt-subclavian junction, indicating limited rotational flow. For the greatest configuration, occurred predominantly along the shunt, at the shunt-subclavian and shunt-PA junctions, aligning with elevated ESR. Negative remained limited, suggesting extensional flow dominated over rotational flow.
Building on the representative least and most thrombogenic configurations, shunt length and tortuosity were varied across the clinically observed range to evaluate their influence on local flow behavior (Figure E4). Across both configurations, shunt length influenced turbulence, but WSR and ESR remained largely unaffected (Figure E5). In the least thrombogenic configuration, the shortest shunt exhibited elevated turbulence (TI = 15.5% at the shunt-PA junction), which decreased and remained low at longer lengths; turbulence remained high across all shunt lengths in the most thrombogenic configuration.
With shunt tortuosity, both configurations showed direction-dependent effects (Figure E6). In the safest configuration, WSR remained nearly unchanged, whereas ESR rose slightly with increasing shunt tortuosity in a way that depended on the direction of curvature (Figure E1); TI remained low and unaffected. In the most thrombogenic configuration, curvature generally reduced WSR relative to the straight shunt, with WSR increasing with shunt tortuosity. Here, ESR trends were nonmonotonic and strongly dependent on curvature direction, whereas TI remained high regardless of tortuosity.
DISCUSSION
Our CFD analysis of 54 mBTTS configurations demonstrated that specific geometric features directly influence thrombosis-related flow. Shunt placement distal to the RCA improved ESR and TI, and acute insertion angles (60°) reduced adverse flow at bifurcations. Smaller PAs (≤3.75 mm) also dampened turbulence. All geometric changes led to significant shifts in WSR, ESR, and/or TI, highlighting the sensitivity of thrombogenic flow to surgical configuration.
Hemodynamic-based strategies to prevent thrombosis are lacking, despite their potential safety advantages. Key flow conditions that increase thrombosis risk, WSR, and ESR at junctions and TI within the shunt, are modifiable. Our virtual analysis identified an optimized geometry; distal shunt insertion, acute PA angle, small , and large , that reduced peak WSR, ESR, and TI by ~50% compared with the least favorable configuration. Several of these features are surgically modifiable, offering opportunities for evidence-based improvement. Although anatomical constraints and surgical exposure may limit full implementation, these findings provide practical targets to reduce thrombogenic flow and guide postoperative risk assessment.
Mechanistic Implications for Thrombosis
Mechanobiological pathways can trigger thrombosis. High WSR can induce shear-induced platelet activation and aggregation through VWF, known to occur as a function of exposure time and shear stresses, observed in <1 second for shear stress exceeding 400 dynes/cm2 (10,000 s−1),17,18 as observed at bifurcations, especially the shunt-subclavian anastomosis. ESR is theoretically shown to induce VWF extension at lower thresholds (100–500 s−1).19,20 ESR is highest within the core of the shunt flow and at the stagnation region, seen as flow impinges on the PAs, which could potentially prime platelets as they hit the wall. Although not fully understood, WSR and ESR could induce mechanical tension across platelet glycoprotein Ib-IX-V (>20 pN) when binding to VWF, triggering granule release and calcium signaling, thereby activating integrins and promoting platelet aggregation.E2 Also, combined ESR and WSR may lead to VWF self-association, potentiating further thrombotic risk.28 More studies are needed to fully understand the role of ESR relative to WSR in causing a thrombotic environment.
TI, which peaked within the shunt conduit, represents a third mechanical pathway to thrombosis. Turbulent flow enhances platelet-platelet collisions and exposure to repeated mechanical stress, potentially amplifying the prothrombotic effects initiated at bifurcations.23 Multiple studies have suggested that transient changes in stress can increase the likelihood for platelet activation.26,E3 Turbulence can also lead to a converse situation of bleeding risk due to its potential role in acquired von Willebrand syndrome (loss of high molecular weight VWF multimers.)E4
Shunt length and tortuosity can modulate WSR, ESR, and TI. Short shunts limit flow development, generating local recirculation and elevated turbulence. Longer shunts allowed laminar flow to develop fully. In most favorable configurations, tortuosity caused minimal change in WSR, but increased ESR due to enhanced elongational stretching along converging streamlines. In most thrombogenic configurations, tortuosity reduced WSR and ESR overall. TI remained largely unchanged by tortuosity. These findings indicate that shunt length shapes the development of flow and alters how blood is distributed into the shunt, whereas mild tortuosity has minimal influence on turbulence but shifts shear and elongational stresses in ways that depend on both the shunt’s geometry and the direction of curvature.
Current antithrombosis strategies target biochemical pathways but have limited efficacy on the mechanical pathways driving thrombosis.22,32,E5–E8 Traditional antiplatelet agents like aspirin have minimal effect on shear-induced platelet activation and aggregation, whereas anticoagulants target the coagulation cascade, which depends on low convection/flow that prevents washout of reaction products,E9 potentially explaining their limited efficacy in preventing mBTTS thrombosis. Caplacizumab, the only drug targeting mechanical pathways, indirectly inhibits VWF-glycoprotein Ib-IX-V binding by stabilizing its autoinhibitory module, but it remains expensive and is primarily used for thrombotic thrombocytopenia purpura rather than surgical thrombosis prevention.E10 Our findings suggest that geometric optimization, by minimizing adverse flow characteristics, could complement pharmacologic strategies, potentially reducing thrombosis risk without increasing bleeding.
Clinical Translation and Surgical Implications
Our computational findings suggest specific surgical adjustments to improve mBTTS outcomes. These include placing the shunt distal to the RCA bifurcation and using a 60° insertion angle into the PA. Although patient anatomical variations (eg, vessel size and branching) may limit full implementation, these hemodynamically informed engineering principles should guide shunt size and placement decisions. In some cases, these adjustments can be made without added complexity, optimizing outcomes while maintaining the core surgical approach.
The 8% to 12% rate of mBTTS thrombosis, with 50% mortality upon occlusion, underscores the need for better strategies.1–7 Our findings suggest that smaller PAs (≤3.75 mm) paired with larger improve otherwise prothrombotic hemodynamics, challenging traditional views on vessel size matching as the primary guiding principle. However, these recommendations must be weighed against individualized anatomical constraints and surgical risks. In patients with single-ventricle physiology, shunts with shorter length or larger diameter have lower resistance, which can predispose to pulmonary overcirculation and systemic steal. Therefore, whereas larger shunts may reduce thrombosis risk, their potential to drive excessive pulmonary flow that diverts blood from coronary and systemic circulation must be considered in surgical planning.
Because outlet flows were prescribed as fixed fractions of total flow to each vessel, based on their diameters rather than on distal vascular resistance, absolute pulmonary-to-systemic flow ratios are not physiologically predictive. Moreover, our simulations encompassed only the innominate artery, the shunt, and the PAs, so systemic flow was not directly evaluated. To compensate, we report resistance across the shunt as a comparative metric for all configurations (Table E3), reflecting the pressure drop required to drive blood through the graft: lower resistance favors greater pulmonary flow, whereas higher resistance limits it and reduces systemic steal.
Power loss values calculated for mBTTS are higher than those reported in Fontan studies.39,E11 Greater power loss indicates less-efficient flow, which is expected due to smaller vessel and shunt sizes when compared with Fontan circulation. Nevertheless, our results help identify designs likely to minimize energy loss and hemodynamic risk in future patient-specific modeling.
In some patients, these findings could be implemented with minimal changes to current surgical practice. Preoperative planning should consider shunt placement relative to the RCA bifurcation, and intraoperative consideration should be placed on maintaining acute insertion angles. Shunt-to-vessel diameter ratio also warrants attention due to its influence on flow. Although exact values may vary, general trends, like favoring acute over obtuse angles, are more important. Further studies are needed to define the geometric parameter space fully.
Although these theoretical recommendations may not apply to every patient, they could help identify those at higher risk for thrombosis, guiding clinical vigilance and management. Geometric optimization complements pharmacologic therapy by targeting mechanical contributors to clot formation without requiring new drugs or protocols. These findings also underscore the value of patient-specific preoperative modeling, enabling surgeons to tailor shunt geometry to individual anatomy.
Limitations and Future Directions
This study has several limitations. Geometric features were derived from a small retrospective cohort, limiting generalizability. Despite this, 54 configurations based on these patients provided statistical strength and give insight into trends. Computationally, steady-state inlet conditions replaced pulsatile flow, and blood was modeled as Newtonian, potentially underestimating low-shear-rate effects. Despite mesh independence, resolution limits may miss fine-scale gradients at sharp transitions. The k- turbulence model with low Reynolds corrections may not fully capture transitional flow. Assumptions of rigid vessel walls and simplified boundary conditions excluded compliance and distal vascular bed resistances. Lastly, only a subset of geometric variables was analyzed.
Validation with in vitro flow models is needed to confirm the predictions. Patient-specific simulations that incorporate complete anatomy and pulsatility could refine geometric recommendations, and large-animal studies may help assess clinical impacts. Development of real-time surgical guidance tools could support intraoperative application of these findings. Ultimately, combining geometric optimization with novel antithrombosis strategies may offer a comprehensive approach to reducing mBTTS thrombosis risk.
CONCLUSIONS
CFD analysis identified mBTTS configurations that may reduce thrombosis risk. Three key findings emerged: shunt placement distal to the RCA consistently lowered prothrombotic flow; acute (60°) PA insertion reduced adverse bifurcation flow; and smaller paired with larger produced more favorable flow profiles, although these must be balanced against patient-specific anatomy. The optimal configuration (distal placement, acute angle, and appropriate vessel sizing) reduced peak adverse flow parameters by ~50% compared with less favorable geometries. Even if only some of these features can be modified surgically, they offer a practical opportunity to optimize shunt design using an evidence-based, hemodynamics-informed approach.
Our findings challenge traditional surgical approaches that prioritize anatomical accessibility over geometric optimization to reduce thrombogenic flow. The strong relationship between shunt geometry and hemodynamics suggests that even modest technical adjustments could meaningfully influence outcomes. Integrating geometry-based optimization with current antithrombosis strategies may offer a complementary and influential approach to improving outcomes in this high-risk population.
Supplementary Material
CENTRAL MESSAGE.
Computational modeling reveals that modified Blalock-Taussig-Thomas shunt geometry directly alters blood flow biomechanics linked to thrombosis, guiding surgical strategies to reduce clotting risk.
PERSPECTIVE.
This study lays the groundwork for precision anticoagulation by integrating patient-specific vascular anatomy, fluid biomechanics, and physics to inform engineering-based surgical planning. Independent of drug-based strategies, this approach offers a novel, mechanistically distinct path to thrombosis prevention in cardiovascular surgery.
Acknowledgments
Supported by The Missouri Chapter of the American College of Cardiology, Washington University Mallinckrodt Institute of Radiology, Washington University Here and Next Seed Grant Program, and the National Institutes of Health/National Center for Advancing Translational Sciences (grant UL1 TR002345). Dr Bark receives funding support from the National Heart, Lung, and Blood Institute (grant No. R01HL164424) and the National Institute of Biomedical Imaging and Bioengineering (grant No. R21EB034579).
Abbreviations and Acronyms
shut-pulmonary artery insertion angle
- CFD
computational fluid dynamics
pulmonary artery diameter
shunt diameter
- ESR
elongation strain rate
distance from shunt to right carotid artery
- mBTTS
modified Blalock-Taussig-Thomas shunt
- PA
pulmonary artery
- RCA
right carotid artery
- TI
turbulence intensity
- VWF
von Willebrand Factor
- WSR
wall shear rate
Footnotes
Conflict of Interest Statement
The authors reported no conflicts of interest.
The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
This manuscript originates from Washington University in St. Louis, where Dr Alexander Patterson, Editor-in-Chief of JTCVS, holds an academic appointment. To maintain the highest standards of editorial integrity and avoid any potential conflict of interest, Dr Patterson was not involved in the editorial review or decision-making process for this submission. Instead, the manuscript was handled by members of the JTCVS editorial leadership, ensuring a fair, independent, and expert peer review.
References
- 1.Giglia TM, Massicotte MP, Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American heart association. Circulation. 2013;128(24):2622–2703. 10.1161/01.cir.0000436140.77832.7a [DOI] [PubMed] [Google Scholar]
- 2.Penk JS, Reddy S, Polito A, et al. Bleeding and thrombosis with pediatric extracorporeal life support: a roadmap for management, research, and the future from the pediatric cardiac intensive care society: part 2. Pediatr Crit Care Med. 2019; 20(11):1034–1039. 10.1097/pcc.0000000000002104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Penk JS, Reddy S, Polito A, et al. Bleeding and thrombosis with pediatric extracorporeal life support: a roadmap for management, research, and the future from the pediatric cardiac intensive care society: part 1. Pediatr Crit Care Med. 2019; 20(11):1027–1033. 10.1097/pcc.0000000000002054 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Giglia TM, Witmer C. Bleeding and thrombosis in pediatric cardiac intensive care. Pediatr Crit Care Med. 2016;17(8 Suppl 1):S287–S295. 10.1097/pcc.0000000000000814 [DOI] [PubMed] [Google Scholar]
- 5.Monagle P. Thrombosis: congenital heart disease and thrombosis: what do we know? Nat Rev Cardiol. 2014;11(3):132–134. 10.1038/nrcardio.2013.217 [DOI] [PubMed] [Google Scholar]
- 6.Garven E, Rodell CB, Shema K, et al. Tunable blood shunt for neonates with complex congenital heart defects. Original research. Front Bioeng Biotechnol. 2022;9:734310. 10.3389/fbioe.2021.734310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg. 2011;92(2):642–651; discussion 651–652. 10.1016/j.athoracsur.2011.02.030 [DOI] [PubMed] [Google Scholar]
- 8.Al Jubair KA, Al Fagih MR, Al Jarallah AS, et al. Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young. 1998;8(4):486–490. 10.1017/s1047951100007150 [DOI] [PubMed] [Google Scholar]
- 9.Ahmad U, Fatimi SH, Naqvi I, et al. Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates. Heart Lung Circ. 2008;17(1):54–58. 10.1016/j.hlc.2007.06.003 [DOI] [PubMed] [Google Scholar]
- 10.de Leval MR, McKay R, Jones M, Stark J, Macartney FJ. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg. 1981;81(1):112–119. [PubMed] [Google Scholar]
- 11.Ilbawi MN, Grieco J, DeLeon SY, et al. Modified Blalock-Taussig shunt in newborn infants. J Thorac Cardiovasc Surg. 1984;88(5 Pt 1):770–775. [PubMed] [Google Scholar]
- 12.O’Connor MJ, Ravishankar C, Ballweg JA, et al. Early systemic-to-pulmonary artery shunt intervention in neonates with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142(1):106–112. 10.1016/j.jtcvs.2010.10.033 [DOI] [PubMed] [Google Scholar]
- 13.Wells WJ, Yu RJ, Batra AS, Monforte H, Sintek C, Starnes VA. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg. 2005;79(6):2072–2076. 10.1016/j.athoracsur.2004.12.050 [DOI] [PubMed] [Google Scholar]
- 14.Pickles DM, Keller K. The economic burden of complex CHD in the United States. Cardiol Young. 2025;35(9):1751–1758. 10.1017/S1047951125109256 [DOI] [PubMed] [Google Scholar]
- 15.Fenton KN, Siewers RD, Rebovich B, Pigula FA. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg. 2003;76(1): 152–156; discussion 156–157. 10.1016/s0003-4975(03)00168-1 [DOI] [PubMed] [Google Scholar]
- 16.Penn E, Qiao Y, Platten K, et al. Impact of vascular geometry on thrombosis in pediatric patients with modified Blalock-Taussig-Thomas shunt: a pilot study. J Am Heart Assoc. 2025;14(6):e038357. 10.1161/JAHA.124.038357 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80(1):113–120. [PubMed] [Google Scholar]
- 18.Hellums JD. 1993 Whitaker lecture: biorheology in thrombosis research. Ann Biomed Eng. 1994;22(5):445–455. 10.1007/bf02367081 [DOI] [PubMed] [Google Scholar]
- 19.Susen S, Rauch A, Van Belle E, Vincentelli A, Lenting PJ. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis. J Thromb Haemost. 2015;13(10):1757–1767. 10.1111/jth.13120 [DOI] [PubMed] [Google Scholar]
- 20.Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56(15):1207–1213. 10.1016/j.jacc.2010.05.016 [DOI] [PubMed] [Google Scholar]
- 21.Sing CE, Alexander-Katz A. Elongational flow induces the unfolding of von Willebrand factor at physiological flow rates. Biophys J. 2010;98(9):L35–L37. 10.1016/j.bpj.2010.01.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bark DL Jr, Para AN, Ku DN. Correlation of thrombosis growth rate to pathological wall shear rate during platelet accumulation. Biotechnol Bioeng. 2012;109 (10):2642–2650. 10.1002/bit.24537 [DOI] [PubMed] [Google Scholar]
- 23.Nesbitt WS, Westein E, Tovar-Lopez FJ, et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med. 2009;15 (6):665–673. 10.1038/nm.1955 [DOI] [PubMed] [Google Scholar]
- 24.Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood. 2003;101(7):2637–2645. 10.1182/blood-2002-05-1550 [DOI] [PubMed] [Google Scholar]
- 25.Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986;78(6):1456–1461. 10.1172/jci112736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zhang JN, Bergeron AL, Yu Q, et al. Platelet aggregation and activation under complex patterns of shear stress. Thromb Haemost. 2002;88(5):817–821. [PubMed] [Google Scholar]
- 27.Nobili M, Sheriff J, Morbiducci U, Redaelli A, Bluestein D. Platelet activation due to hemodynamic shear stresses: damage accumulation model and comparison to in vitro measurements. Asaio J. 2008;54(1):64–72. 10.1097/MAT.0b013e31815d6898 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Herbig BA, Diamond SL. Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation. J Thromb Haemost. 2015;13(9): 1699–1708. 10.1111/jth.13044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Springer TA. von Willebrand factor, Jedi knight of the bloodstream. Blood. 2014; 124(9):1412–1425. 10.1182/blood-2014-05-378638 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bozzi S, Dominissini D, Redaelli A, Passoni G. The effect of turbulence modelling on the assessment of platelet activation. J Biomech. 2021;128:110704. 10.1016/j.jbiomech.2021.110704 [DOI] [PubMed] [Google Scholar]
- 31.Stein PD, Sabbah HN. Measured turbulence and its effect on thrombus formation. Circ Res. 1974;35(4):608–614. 10.1161/01.res.35.4.608 [DOI] [PubMed] [Google Scholar]
- 32.Grande Gutiérrez N, Mukherjee D, Bark D Jr. Decoding thrombosis through code: a review of computational models. J Thromb Haemost. 2024;22(1): 35–47. 10.1016/j.jtha.2023.08.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Williams D, Leuthardt EC, Genin GM, Zayed M. Tailoring of arteriovenous graft-to-vein anastomosis angle to attenuate pathological flow fields. Sci Rep. 2021;11(1):12153. 10.1038/s41598-021-90813-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Buehler MJ, Genin GM. Integrated multiscale biomaterials experiment and modelling: a perspective. Interf Focus. 2016;6(1):20150098. 10.1098/rsfs.2015.0098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Kong F, Stocker S, Choi PS, Ma M, Ennis DB, Marsden AL. SDF4CHD: generative modeling of cardiac anatomies with congenital heart defects. Med Image Anal. 2024;97:103293. 10.1016/j.media.2024.103293 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kong F, Shadden SC. Learning whole heart mesh generation from patient images for computational simulations. IEEE Trans Med Imaging. 2023;42(2):533–545. 10.1109/tmi.2022.3219284 [DOI] [PubMed] [Google Scholar]
- 37.Kong F, Shadden SC. Automating model generation for image-based cardiac flow simulation. J Biomech Eng. 2020;142(11):111011. 10.1115/1.4048032 [DOI] [PubMed] [Google Scholar]
- 38.Murray CD. The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A. 1926;12(3):207–214. 10.1073/pnas.12.3.207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Restrepo M, Tang E, Haggerty CM, et al. Energetic implications of vessel growth and flow changes over time in Fontan patients. Ann Thorac Surg. 2015;99(1): 163–170. 10.1016/j.athoracsur.2014.08.046 [DOI] [PubMed] [Google Scholar]
- 40.Astarita G. Objective and generally applicable criteria for flow classification. J Non-Newtonian Fluid Mech. 1979;6(1):69–76. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
